Location History:
- Weisbaden, DE (2010)
- Wiesbaden, DE (2006 - 2014)
- Frankfurt-am-Main, DE (2016)
Company Filing History:
Years Active: 2006-2016
Title: Johann Gassenhuber: Innovator in Biosynthesis and Cardiovascular Research
Introduction
Johann Gassenhuber, located in Wiesbaden, Germany, is a prominent inventor with a notable portfolio of five patents. His work primarily focuses on biosynthesis and cardiovascular research, contributing significantly to the fields of medicine and pharmaceuticals.
Latest Patents
Gassenhuber's latest innovations include two significant patents. The first, titled "Gene cluster for biosynthesis of griselimycin and methylgriselimycin," pertains to a specific gene cluster responsible for producing these antibiotic agents. This invention emphasizes the potential applications of these genes and their encoded proteins in developing crucial antibiotic treatments.
The second patent, "Method of screening a modulator of endothelial NO synthase comprising the use of heme binding protein 1," introduces a method for identifying modulators that can influence endothelial nitric oxide synthase (eNOS) expression. This innovation holds promise for diagnosing cardiovascular diseases and discovering new medications aimed at preventing or treating conditions related to eNOS dysfunction.
Career Highlights
Throughout his career, Gassenhuber has worked with respected companies in the pharmaceutical sector, including Sanofi and Sanofi-Aventis Deutschland GmbH. His contributions to these organizations have allowed him to leverage his innovative ideas and collaborate with leading scientists, advancing the frontiers of medical research.
Collaborations
In his professional journey, Gassenhuber has collaborated with notable colleagues, including Evi Kostenis and Mark Broenstrup. These collaborations have enriched his research endeavors and fostered a productive exchange of ideas, which is vital for innovative breakthroughs in science.
Conclusion
Johann Gassenhuber's contributions to the realms of biosynthesis and cardiovascular research demonstrate his commitment to innovation and excellence. His patents not only reflect his inventiveness but also hold the potential to significantly impact future medical treatments and advancements in healthcare.